EKF Diagnostics (LON:EKF) Stock Crosses Below 200-Day Moving Average – Here’s Why

EKF Diagnostics Holdings plc (LON:EKF)’s share price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 27.25 and traded as low as GBX 26.88. EKF Diagnostics shares last traded at GBX 28.40, with a volume of 286,552 shares changing hands.

EKF Diagnostics Stock Performance

The company has a market cap of £122.51 million, a PE ratio of 20.91 and a beta of 0.57. The stock’s 50 day simple moving average is GBX 25.22 and its two-hundred day simple moving average is GBX 27.25. The company has a quick ratio of 1.77, a current ratio of 4.60 and a debt-to-equity ratio of 0.34.

Insider Buying and Selling at EKF Diagnostics

In other news, insider Julian Baines bought 85,000 shares of EKF Diagnostics stock in a transaction that occurred on Monday, December 15th. The shares were purchased at an average price of GBX 23 per share, for a total transaction of £19,550. Company insiders own 39.62% of the company’s stock.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.